ROBERT FRIEDMAN: Open Payments
NPI 1457337446 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 30 payments from 10 companies in 2025. Trend: 2023 $514 · 2024 $11,713 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $147 |
| ITF Therapeutics LLC | 4 | $110 |
| Ipsen Biopharmaceuticals, Inc | 3 | $84 |
| PIRAMAL CRITICAL CARE | 4 | $72 |
| SPINEFRONTIER, INC. | 2 | $44 |
| HydroCision, Inc. | 1 | $41 |
| PFIZER INC. | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| GENZYME CORPORATION | 1 | $22 |
Products named: BOTOX, Dysport, GABLOFEN, Inspan, TENJET, QULIPTA, NURTEC ODT, RELISTOR.
Industry payments across ID — which companies pay providers there.
